These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 19104406
21. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens. Wlodarczyk Z, Walaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradszky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Kalmar KN, Hickey D. Transpl Int; 2005 Feb; 18(2):157-62. PubMed ID: 15691267 [Abstract] [Full Text] [Related]
22. A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation. Sánchez-Lázaro IJ, Almenar L, Martínez-Dolz L, Buendía-Fuentes F, Agüero J, Navarro-Manchón J, Vicente JL, Salvador A. Clin Transplant; 2011 Feb; 25(4):606-13. PubMed ID: 20682020 [Abstract] [Full Text] [Related]
23. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis. Stratta RJ, Alloway RR, Hodge E, Lo A, Pancreas Investigators Vital Outcomes Trial (PIVOT) Study Group. Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617 [Abstract] [Full Text] [Related]
24. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I. Transplantation; 1997 Dec 27; 64(12):1755-60. PubMed ID: 9422416 [Abstract] [Full Text] [Related]
26. Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens. Krämer BK, Krüger B, Mack M, Obed A, Banas B, Paczek L, Schlitt HJ. Transplant Proc; 2005 May 27; 37(4):1789-91. PubMed ID: 15919467 [Abstract] [Full Text] [Related]
27. Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. Kato T, Gaynor JJ, Yoshida H, Montalvano M, Takahashi H, Pyrsopoulos N, Nishida S, Moon J, Selvaggi G, Levi D, Ruiz P, Schiff E, Tzakis A. Transplantation; 2007 Oct 15; 84(7):829-35. PubMed ID: 17984834 [Abstract] [Full Text] [Related]
28. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A. Transplantation; 2006 Jul 15; 82(1):62-8. PubMed ID: 16861943 [Abstract] [Full Text] [Related]
30. The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients. Kuypers DR, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y. Clin Transplant; 2003 Jun 15; 17(3):234-41. PubMed ID: 12780674 [Abstract] [Full Text] [Related]